Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects:

Level classification and summary of total scores of KAP towards hypertension among caregivers at baseline assessment and at week six assessment (n = 422). by Chikondi Maluwa (20660522)

Subjects:

Mean KAP scores and standard deviation at different assessment times. by Chikondi Maluwa (20660522)

Subjects:

Participants’ summary of total KAP scores at different assessment times. by Chikondi Maluwa (20660522)

Subjects:

Socio-demographic characteristics of hypertensive patients’ caregivers (n = 422). by Chikondi Maluwa (20660522)

Subjects:

Participants enrollment. by Chikondi Maluwa (20660522)

Subjects:

Comparison of knowledge retention among different socio-demographic factors using independent t-test (n = 422). by Chikondi Maluwa (20660522)

Subjects:

KAP assessment scores (n = 422). by Chikondi Maluwa (20660522)

Subjects:

Pearson correlation test, correlations between KAP and correlations between age and KAP at baseline and six weeks post-health education (n = 422). by Chikondi Maluwa (20660522)

Subjects:

Simulations show that microSLAM improves power and false positive rates. by Miriam Goldman (21433180)

Decreased IL-1 and inflammasome, and chemokine gene expression pattens in response to Pam3CSK4 in BRD diagnosed calves. by Cian Reid (17274007)

Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases. by Spela Kokelj (8356644)

Subjects:

Correlation between protein abundances and R_5-20 z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

Subjects:

General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

Subjects:

Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

Subjects:

Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

Subjects: